Free Sample Issue: Another Take on FDA's Remote Inspection Authority for Devices, Updates to Software Documentation in Pre-Market Submissions + GMP Warning Letter Breakdown
We dive deeper into expanding FDA's authority to remotely review device companies, outline changes to pre-market submissions for devices with software, and look at trending GMP issues.
We also look inside a new draft guidance from CDRH that would update the way software is documented in pre-market submissions.
Lastly, we distill some key points from a recent warning letter issued to…
Watch with a 7-day free trial
Subscribe to The FDA Group's Insider Newsletter to watch this video and get 7 days of free access to the full post archives.